Filing Details
- Accession Number:
- 0001735276-22-000067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-05 16:15:21
- Reporting Period:
- 2022-08-03
- Accepted Time:
- 2022-08-05 16:15:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1849458 | Tolga Tanguler | 675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-03 | 3,629 | $0.00 | 5,383 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2022-08-03 | 1,754 | $210.00 | 3,629 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-04 | 1,618 | $189.76 | 2,011 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-08-04 | 170 | $210.50 | 1,841 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-08-05 | 149 | $215.03 | 1,692 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-05 | 398 | $216.21 | 1,294 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-05 | 440 | $217.61 | 854 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-05 | 541 | $218.71 | 313 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-05 | 99 | $219.53 | 214 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-05 | 105 | $220.95 | 109 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-05 | 5 | $224.00 | 104 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-05 | 104 | $225.15 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- On February 24, 2021, the reporting person was granted a one-time strategic performance-based stock unit (PSU) award. The People, Culture and Compensation Committee of the Board determined that the performance criterion was met and the PSU award vested as of August 3, 2022.
- These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.
- Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting event.
- Sale prices ranged from $214.86 to $215.13.
- Sale prices ranged from $216.01 to $217.01.
- Sale prices ranged from $217.10 to $218.10
- Sale prices ranged from $218.14 to $219.09.
Billionaire Hedge Funds
